Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease

Phase 4 Completed 60 enrolled Florida Atlantic University Forest Laboratories · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine whether memantine delays the progression of driving impairment in patients with mild Alzheimer's Disease (AD).

Timeline

Start: 2007-07
Primary completion: 2012-10
Completion: 2012-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Memantine	Unknown	10 mg	—

Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease

Summary

Timeline

Drugs

Indications